COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours

Bookmark and Share
Published: 27 May 2020
Views: 99
Rating:
Save
Dr. Ecaterina Dumbrava - MD Anderson Cancer Centre, Houston, USA

Dr Ecaterina Dumbrava speaks to ecancer online about the trial of COM701as a monotherapy and in combination with nivolumab which was presented that the AACR 2020 virtual meeting.

Dr Dumbrava outlines the trial design, including the monotherapy and combination (with nivolumab) arms.

She provides overall data, and also specific patient examples, which looks very promising especially considering the low level of toxicity.